The recent crash in Granules share price is a nightmare for small investors and this is precisely the risk of overdependence on US market. In normal situation this should have been an opportunity to buy, but given the seriousness of FDA observations, it would be naive to buy without knowing the details of repercussions. At the sametime Motilal has given a buy call.
So learned friends with domain knowledge may throw light on it and expected turnaround in companies business. As there is no doubt about the quality of the management here, there is no risk of company evaporating.
| Subscribe To Our Free Newsletter |
